MREO (Mereo BioPharma Group) Shares Outstanding (Diluted Average): 160.71 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MREO Mereo BioPharma Group PLC MREO
21 GF Score
Price $0.29
! 1 Warning Sign
View Full Analysis

What is Mereo BioPharma Group Shares Outstanding (Diluted Average)?

Mereo BioPharma Group MREO -6.09% 21 Shares Outstanding (Diluted Average) is 160.71 Mil as of Jun. 2026. GuruFocus rates MREO with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Mereo BioPharma Group's average diluted shares outstanding for the quarter that ended in Jun. 2026 was 160.71 Mil.

Mereo BioPharma Group  (NAS:MREO) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

Mereo BioPharma Group Shares Outstanding (Diluted Average) Related Terms

Mereo BioPharma Group Shares Outstanding (Diluted Average) Historical Data

* Premium members only.

The historical data trend for Mereo BioPharma Group's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mereo BioPharma Group Shares Outstanding (Diluted Average) Chart

Mereo BioPharma Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Diluted Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.73 120.64 131.89 147.92 159.42

Mereo BioPharma Group Quarterly Data
Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (Diluted Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.89 159.99 159.13 160.36 160.71
MREO
21GF Score
Mereo BioPharma Group PLC MREO
Shares Outstanding (Diluted Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mereo BioPharma Group Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Diluted Average) of 160.71 Mil mean?
Mereo BioPharma Group (MREO) has a Shares Outstanding (Diluted Average) of 160.71 Mil as of Jun. 2026. The average shares outstanding over two periods including dilutive securities like preferred shares and convertibles. View historical data on Mereo BioPharma Group and its competitors.
Is Mereo BioPharma Group's Shares Outstanding (Diluted Average) too high?
Mereo BioPharma Group's current Shares Outstanding (Diluted Average) is 160.71 Mil. Overall, Mereo BioPharma Group has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Mereo BioPharma Group's Shares Outstanding (Diluted Average) compare to ACTU and CRVO?
Mereo BioPharma Group's Shares Outstanding (Diluted Average) of 160.71 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Diluted Average) for a Biotechnology company?
A good Shares Outstanding (Diluted Average) depends on the Biotechnology industry context. However, Shares Outstanding (Diluted Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Diluted Average) mean?
A high Shares Outstanding (Diluted Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods including dilutive securities like preferred shares and convertibles. View historical data on Mereo BioPharma Group and its competitors. Mereo BioPharma Group's current Shares Outstanding (Diluted Average) is 160.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mereo BioPharma Group stock overvalued right now?
Mereo BioPharma Group (MREO) has a current Shares Outstanding (Diluted Average) of 160.71 Mil. The current Shares Outstanding (Diluted Average) is 160.71 Mil. Mereo BioPharma Group's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Diluted Average) calculated?
Shares Outstanding (Diluted Average) is calculated from a company's financial statements. For Mereo BioPharma Group (MREO), the current Shares Outstanding (Diluted Average) is 160.71 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mereo BioPharma Group Business Description

Other Exchanges 0A9G:UKMAH0:Germany
Address One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
21GF Score

Get the complete analysis for MREO

Shares Outstanding (Diluted Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price